5-(4,4,5,5-Tetramethyl-1,3,2-dioxaborolan-2-yl)-2,2'-bipyridine, 98%, 100mg

(S)-tert-Butyl 2-(bromomethyl)morpholine-4-carboxylate, 95.0%, 250mg

6-BROMO-2,2-DIMETHYL-2H-BENZO[B][1,4]OXAZIN-3(4H)-ONE, 97.0%, 10g

2-Methoxy-4-(pyridin-2-ylmethoxy)benzaldehyde, 97%, 1g

(2S,4R)-1-(tert-Butoxycarbonyl)-4-cyanopyrrolidine-2-carboxylic acid, 97%, 500mg

ethyl 2-(2-aminoethyl)-1,3-thiazole-4-carboxylate dihydrochloride, 95.0%, 1g

3-aminophénol, min.99%, pour la synthèse, 500 g, emballage en verre

3-(Trifluoromethoxy)anisole, 95.0%, 5g

2,5-dichloro-2'-(4-methylpiperazinomethyl) benzophenone, 97.0%, 1g

4-(3,5-dichlorobenzoyl)-8-methyl-1-oxa-4-azaspiro[4.5]decane-3-carboxylic acid, 95.0%, 1g

3,4-dichloro-4'-piperidinomethyl benzophenone, 97.0%, 1g

4-BROMO-2,6-DICHLOROBENZYL ALCOHOL, 95.0%, 250mg

1-(1-Methyl-1H-indazol-7-yl)ethanone, 95.0%, 1g